1. Home
  2. LZM vs VNDA Comparison

LZM vs VNDA Comparison

Compare LZM & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifezone Metals Limited

LZM

Lifezone Metals Limited

HOLD

Current Price

$3.75

Market Cap

391.3M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.07

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZM
VNDA
Founded
2021
2002
Country
Isle of Man
United States
Employees
93
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
391.3M
361.4M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
LZM
VNDA
Price
$3.75
$6.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$7.00
$14.90
AVG Volume (30 Days)
741.0K
887.6K
Earning Date
03-19-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
$86.37
$21.35
Revenue Next Year
$202.49
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$3.07
$4.14
52 Week High
$6.40
$9.91

Technical Indicators

Market Signals
Indicator
LZM
VNDA
Relative Strength Index (RSI) 43.08 49.21
Support Level $3.62 $5.97
Resistance Level $4.32 $6.73
Average True Range (ATR) 0.32 0.23
MACD -0.02 0.05
Stochastic Oscillator 22.32 81.36

Price Performance

Historical Comparison
LZM
VNDA

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania, and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate. Geographically, the company operates in South Africa, Australia, and the rest of the world. The majority of its revenue is generated from Australia.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: